Olema Pharmaceuticals, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.65M
Gross Profit -0.65M
Operating items
Research & Development 13.70M
Selling, General & Administrative 7.82M
Operating Expenses 21.53M
Operating Income -21.53M
EBIT -21.53M
Non-operating items
Interest & Investment Income 0.06M
Non Operating Income -0.59M
Net income details
EBT -22.12M
Profit After Tax -22.12M
Income from Continuing Operations -22.12M
Consolidated Net Income -22.12M
Income towards Parent Company -22.12M
Net Income towards Common Stockholders -23.99M
Additional items
EPS (Basic) -0.00M
EPS (Weighted Average and Diluted) -0.00M
Shares Outstanding (Weighted Average) 37.52M40.29M40.46M54.77M57.30M
EBITDA -21.53M